APA (7th ed.) Citation

Alquhaidan, M., Albokhadaim, I., Almofti, Y. A., Al-Rasheed, M., Mahmoud, M., Azhari, A., . . . Kandeel, M. (2025). Entecavir in Hepatitis B Treatment: A 25-Year Bibliometric Journey (2001-2025) Through Trends, Themes, and Therapeutic Advances. International Journal of Nutrition, Pharmacology, Neurological Diseases, 15(4), 438. https://doi.org/10.4103/ijnpnd.ijnpnd_133_25

Chicago Style (17th ed.) Citation

Alquhaidan, Mohammed, Ibrahim Albokhadaim, Yassir A. Almofti, Mohammed Al-Rasheed, Maryam Mahmoud, Alaa Azhari, Afzal A. Assif, and Mahmoud Kandeel. "Entecavir in Hepatitis B Treatment: A 25-Year Bibliometric Journey (2001-2025) Through Trends, Themes, and Therapeutic Advances." International Journal of Nutrition, Pharmacology, Neurological Diseases 15, no. 4 (2025): 438. https://doi.org/10.4103/ijnpnd.ijnpnd_133_25.

MLA (9th ed.) Citation

Alquhaidan, Mohammed, et al. "Entecavir in Hepatitis B Treatment: A 25-Year Bibliometric Journey (2001-2025) Through Trends, Themes, and Therapeutic Advances." International Journal of Nutrition, Pharmacology, Neurological Diseases, vol. 15, no. 4, 2025, p. 438, https://doi.org/10.4103/ijnpnd.ijnpnd_133_25.